A detailed history of Skba Capital Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Skba Capital Management LLC holds 428,850 shares of PFE stock, worth $11.5 Million. This represents 1.93% of its overall portfolio holdings.

Number of Shares
428,850
Previous 411,850 4.13%
Holding current value
$11.5 Million
Previous $11.5 Million 7.7%
% of portfolio
1.93%
Previous 1.92%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$27.7 - $31.39 $470,900 - $533,630
17,000 Added 4.13%
428,850 $12.4 Million
Q2 2024

Aug 12, 2024

BUY
$25.26 - $29.6 $2.47 Million - $2.89 Million
97,750 Added 31.12%
411,850 $11.5 Million
Q1 2024

May 13, 2024

BUY
$25.89 - $29.73 $504,855 - $579,735
19,500 Added 6.62%
314,100 $8.72 Million
Q4 2023

Feb 12, 2024

BUY
$26.13 - $33.94 $7.7 Million - $10 Million
294,600 New
294,600 $8.48 Million
Q3 2022

Nov 10, 2022

SELL
$43.76 - $53.42 $150,972 - $184,299
-3,450 Reduced 33.01%
7,000 $306,000
Q1 2022

May 12, 2022

SELL
$45.75 - $56.69 $32,025 - $39,683
-700 Reduced 6.28%
10,450 $541,000
Q4 2021

Feb 10, 2022

SELL
$41.32 - $61.25 $86,772 - $128,625
-2,100 Reduced 15.85%
11,150 $658,000
Q3 2021

Nov 10, 2021

BUY
$39.25 - $50.42 $3,925 - $5,042
100 Added 0.76%
13,250 $570,000
Q2 2021

Aug 12, 2021

BUY
$35.91 - $40.68 $73,615 - $83,394
2,050 Added 18.47%
13,150 $515,000
Q1 2021

May 13, 2021

SELL
$33.49 - $37.77 $38,513 - $43,435
-1,150 Reduced 9.39%
11,100 $402,000
Q4 2020

Feb 10, 2021

BUY
$33.47 - $42.56 $192,452 - $244,720
5,750 Added 88.46%
12,250 $451,000
Q3 2020

Nov 12, 2020

BUY
$31.75 - $37.25 $206,375 - $242,125
6,500 New
6,500 $239,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Skba Capital Management LLC Portfolio

Follow Skba Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skba Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Skba Capital Management LLC with notifications on news.